|Last Price$87.99||Day Change (%)2.10%|
|Open Price$87.96||Day Change ($)1.81|
|Day Range86.19–88.39||52-Week Range47.03–112.57|
As of Mon 10/20/2014 03:51 PM EST | USD
Alnylam Reports Six-Month Clinical Data from Patisiran Phase 2 Open-Label Extension (OLE) Study in Patients with Familial Amyloidotic Polyneuropathy (FAP)
Research and Markets: Global Paroxysmal Nocturnal Hemoglobinuria Therapeutics Pipeline 2014 - 5 Companies & 9 Drug Profiles
Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.